Search results for "Peg"

showing 10 items of 460 documents

Evolutionary dynamics of the E1-E2 viral populations during combination therapy in non-responder patients chronically infected with hepatitis C virus…

2012

Abstract Half of the patients chronically infected with hepatitis C virus (HCV) genotype 1 fail to respond to pegylated interferon alpha (PEG-IFN) and ribavirin (RBV) therapy. This study assesses the effects of treatment on the evolution of the E1–E2 viral region in non-responder patients infected with HCV-1b. Twenty-three HCV-1b chronically infected patients were studied retrospectively, including 19 non-responders to PEG-IFN/RBV therapy (11 null-responders and 8 relapsers) in the study group, and 4 untreated patients in the control group. Genetic and phylogenetic analyses of the E1–E2 viral populations were performed at baseline and at the time of treatment failure to assess changes in ge…

Microbiology (medical)AdultMaleCombination therapyHepatitis C virusAdaptation BiologicalHepacivirusBiologymedicine.disease_causeMicrobiologyAntiviral AgentsEvolution Molecularchemistry.chemical_compoundViral Envelope ProteinsPegylated interferonGenotypeGeneticsmedicineHumansGenetic variabilityTreatment FailureMolecular BiologyEcology Evolution Behavior and SystematicsPhylogenyAgedRetrospective StudiesGenetic diversityRibavirinGenetic VariationHepatitis C ChronicMiddle AgedViral LoadVirologyInfectious DiseaseschemistryAmino Acid SubstitutionViral evolutionImmunologyDrug Therapy CombinationFemalemedicine.drugInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
researchProduct

Chronic hepatitis B: who to treat and which choice of treatment?

2009

The goal of antiviral therapy in patients with chronic hepatitis B is to prevent, through persistent suppression of HBV replication, cirrhosis and hepatocellular carcinoma. Currently, seven drugs are available: IFN-alpha, pegylated interferon, lamivudine, adefovir dipivoxil, entecavir, telbivudine and tenofovir. The choice of the drugs should always take into consideration the clinical features of patients, the antiviral efficacy of each drug, the risk of developing resistance, the long-term safety profile, the method of administration and the cost of therapy. Ideal candidates for treatment are hepatitis B e antigen-positive patients with a prolonged phase of immune clearance and hepatitis …

Microbiology (medical)Liver Cirrhosismedicine.medical_specialtyHepatitis B virusCarcinoma Hepatocellularmedicine.disease_causeVirus ReplicationMicrobiologyGastroenterologyAntiviral AgentsDrug Administration ScheduleHepatitis B ChronicPegylated interferonVirologyTelbivudineInternal medicineDrug Resistance ViralmedicineAdefovirHumansRandomized Controlled Trials as TopicHepatitis B virusbusiness.industryNucleotidesLamivudineNucleosidesEntecavirHepatitis Bmedicine.diseaseVirologyInfectious DiseasesPractice Guidelines as TopicHepatitia BbusinessViral hepatitisantiviral Therapymedicine.drugExpert review of anti-infective therapy
researchProduct

New nanobiohybrid engineering composed of titanate nanoribbons for regenerative medicine

2012

This research work is devoted to new nanohybrid engineering composed of titanate nanoribbons for regenerative medicine. Over a first phase, nanoribbons were synthesized by hydrothermal treatment and their morphological, structural and chemical features were defined. A fine characterization by means of different techniques of transmission electron microscopy mainly enabled to determine their thickness; dimension which had never been measured so far. Subsequently, titanate nanoribbons were functionalized by different home-made heterobifunctional PEG. Those polymers present at one of their extremities specific functional groups being able to couple with numerous biological molecules. Some coll…

NanobiohybridFonctionnalisationHydrogel d’alginateProteinsNanobiohybrideProtéinesPEG hétérobifonctionnelAlginate hydrogelHeterobifunctional PEG[CHIM.OTHE] Chemical Sciences/OtherRegenerative medicineTitanate nanoribbonsFunctionalizationMédecine régénérativeNanorubans de titanates
researchProduct

Multifunctional superparamagnetic MnO@SiO2 core/shell nanoparticles and their application for optical and magnetic resonance imaging

2012

Highly biocompatible multifunctional nanocomposites consisting of monodisperse manganese oxide nanoparticles with luminescent silica shells were synthesized by a combination of w/o-microemulsion techniques and common sol–gel procedures. The nanoparticles were characterized by TEM analysis, powder XRD, SQUID magnetometry, FT-IR, UV/vis and fluorescence spectroscopy and dynamic light scattering. Due to the presence of hydrophilic poly(ethylene glycol) (PEG) chains on the SiO2 surface, the nanocomposites are highly soluble and stable in various aqueous solutions, including physiological saline, buffer solutions and human blood serum. The average number of surface amino groups available for lig…

NanocompositeMaterials scienceDispersityAnalytical chemistryNanoparticleGeneral ChemistryFluorescence spectroscopychemistry.chemical_compoundDynamic light scatteringchemistryChemical engineeringPEG ratioMaterials ChemistryEthylene glycolSuperparamagnetismJournal of Materials Chemistry
researchProduct

Elaboration of functionalized nanoparticles : applications as MRI contrast agent

2010

Spinel structured iron oxide nanoparticles open the way of biomedical applications of nanomaterials.Superparamagnetic properties of ten nanometer size crystallites permit to use them in diagnosis such as Magnetic Resonance Imaging (MRI).The aim of this work was to synthesize colloidal suspension of magnetite or maghemite (called USPIO for Ultrasmall SuperParamagnetic Iron Oxide) stable in physiological conditions (pH = 7.4 and [NaCl] = 0.15M).By classical co-precipitation method, UPSIO were synthesized with a mean crystallite size of 8 nm, with a specific surface area of 110 m².g-1 and an aggregate size of 20 nm. To stabilize these nano-objects, two ways were investigated. Electrostatic age…

NanohybridsFe3O4Acide citrique[ PHYS.COND.CM-GEN ] Physics [physics]/Condensed Matter [cond-mat]/Other [cond-mat.other]RelaxivitéUSPIOCytotoxicité des nanoparticulesCitric acidDMSANanoparticles cytotoxicityNanohybrides[CHIM.OTHE] Chemical Sciences/Other[PHYS.COND.CM-GEN] Physics [physics]/Condensed Matter [cond-mat]/Other [cond-mat.other][PHYS.COND.CM-GEN]Physics [physics]/Condensed Matter [cond-mat]/Other [cond-mat.other][ CHIM.OTHE ] Chemical Sciences/OtherMPEG-SiEau supercritiqueRelaxivity[CHIM.OTHE]Chemical Sciences/OtherMRISupercritical waterIRM
researchProduct

GraftFast Surface Engineering to Improve MOF Nanoparticles Furtiveness

2018

International audience; Controlling the outer surface of nanometric metal–organic frameworks (nanoMOFs) and further understanding the in vivo effect of the coated material are crucial for the convenient biomedical applications of MOFs. However, in most studies, the surface modification protocol is often associated with significant toxicity and/or lack of selectivity. As an alternative, how the highly selective and general grafting GraftFast method leads, through a green and simple process, to the successful attachment of multifunctional biopolymers (polyethylene glycol (PEG) and hyaluronic acid) on the external surface of nanoMOFs is reported. In particular, effectively PEGylated iron trime…

Nanoparticle02 engineering and technologyPolyethylene glycol[CHIM.THER]Chemical Sciences/Medicinal ChemistrySurface engineering010402 general chemistry01 natural sciencesBiomaterialschemistry.chemical_compoundAdsorptionPEG ratio[CHIM]Chemical SciencesGeneral Materials ScienceComputingMilieux_MISCELLANEOUSChemistry[CHIM.ORGA]Chemical Sciences/Organic chemistryGeneral Chemistry[CHIM.MATE]Chemical Sciences/Material chemistry021001 nanoscience & nanotechnologyGrafting0104 chemical sciencesChemical engineeringSurface modification0210 nano-technologySelectivityBiotechnology
researchProduct

Production of polymeric micro- and nanostructures with tunable properties as pharmaceutical delivery systems

2020

Abstract The production of novel graft copolymers based on poly-e-caprolactone (PCL) and polyaspartamide are useful to realize structures for potential biomedical applications. Here, the synthesis of pegylated PCL/polyhydroxyethyl aspartamide (PHEA) graft copolymers (PHEA-g-SUCC-PCL-g-PEG) with tunable composition, was achieved by followpling a synthetic strategy that involved first the grafting of preformed PCL on PHEA backbone, then polyethylen glycol (PEG), by using 1,1′-carbonyldiimidazole (CDI) to speed up the condensation reaction. Graft copolymers with a Derivatization Degree (DD) in PCL ranging between 1.1 and 4.4 mol% were obtained, and processable with different technologies for t…

NanostructureMaterials sciencePolymers and PlasticsMicrofluidicsNanoparticlemacromolecular substances02 engineering and technology010402 general chemistry01 natural sciencesPEG ratioMaterials ChemistryCopolymerOrganic Chemistrytechnology industry and agricultureαβ-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA)equipment and suppliesmusculoskeletal system021001 nanoscience & nanotechnologyCondensation reactionGrafting0104 chemical sciencesGraft copolymerChemical engineeringMicrofluidicMicroparticlePoly-ε-caprolactone (PCL)Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoNanoparticles0210 nano-technologyNanoprecipitation
researchProduct

Effect of Polymer Length on the Adsorption onto Aluminogermanate Imogolite Nanotubes

2021

This study evidences the adsorption of model nonionic polymers onto aluminogermanate imogolite nanotubes, attractive porous nanofillers with potential molecular loading and release applications. We resolve the underlying mechanisms between nanotubes and polyethylene glycols with different molecular weights by means of nanoisothermal titration calorimetry. The analysis of the results provides a direct thermodynamic characterization, allowing us to propose a detailed description of the energetics involved in the formation of polymer/imogolite complexes. The affinity toward the nanotube surface is enthalpy-driven and strongly depends on the polymer chain length, which significantly affects the…

NanotubeMaterials scienceImogolite02 engineering and technologyCalorimetryNeutron scattering010402 general chemistry01 natural sciencesSettore CHIM/12 - Chimica Dell'Ambiente E Dei Beni Culturalichemistry.chemical_compoundAdsorptionRheologyElectrochemistryGeneral Materials ScienceComputingMilieux_MISCELLANEOUSSpectroscopySettore CHIM/02 - Chimica Fisicachemistry.chemical_classificationQuantitative Biology::BiomoleculesSurfaces and InterfacesPolymerPolyethylene021001 nanoscience & nanotechnologyCondensed Matter Physics0104 chemical sciencesCondensed Matter::Soft Condensed MatterchemistryChemical engineeringImogolite nanotubes SANS ITC PEGs[PHYS.PHYS.PHYS-CHEM-PH]Physics [physics]/Physics [physics]/Chemical Physics [physics.chem-ph]0210 nano-technology[PHYS.COND.CM-SCM]Physics [physics]/Condensed Matter [cond-mat]/Soft Condensed Matter [cond-mat.soft]
researchProduct

Time spent on the smartphone does not relate to manual dexterity in young adults.

2021

Abstract Background The Grooved Pegboard Test (GPT) is widely adopted to evaluate manual dexterity, it presents normative data but the test is influenced by different factors. The influence of time spent on smartphones has not been considered before, for this reason, the objective of this study was to evaluate if smartphone use influences the time to complete the GPT. A total of 38 (21 women; 17 men) young adults 20.7 (1.5) years participated in the study. The time spent on the smartphones during the last seven days was recorded through the device itself and the GPT performance was measured. A correlation analysis between the time spent on the smartphone and GPT was performed while the t-te…

Neurophysiology and neuropsychologyMalemedicine.medical_specialtyanimal structuresmanual dexterityTime FactorsCognitive function Grooved pegboard test Manual dexterity Mobile phone PhoneNeurosciences. Biological psychiatry. NeuropsychiatryAudiologyphone03 medical and health sciencesCellular and Molecular NeuroscienceYoung Adult0302 clinical medicinemedicineHumansYoung adultcognitive functionmobile phoneQP351-495General Neurosciencegrooved pegboard test030229 sport sciencesTest (assessment)Motor SkillsCorrelation analysisFemaleSmartphonePsychology030217 neurology & neurosurgeryResearch ArticleRC321-571Grooved Pegboard TestBMC neuroscience
researchProduct

Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report

2018

Abstract Background The approach to acromegalic patients with persistent acromegaly after surgery and inadequate response to first-generation somatostatin receptor ligands (SRLs) should be strictly tailored. Current options include new pituitary surgery and/or radiosurgery, or alternative medical treatment with SRLs high dose regimens, pegvisomant (PEG) as monotherapy, or combined therapy with the addition of PEG or cabergoline to SRLs. A new pharmacological approach includes pasireotide, a second-generation SRL approved for patients who do not adequately respond to surgery and/or for whom surgery is not an option. No reports on efficacy and safety of combined therapy with pasireotide and p…

OncologyAdultMalemedicine.medical_specialtyCabergolineEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPegvisomant030209 endocrinology & metabolismCase ReportAntineoplastic Agentslcsh:Diseases of the endocrine glands. Clinical endocrinologyRadiosurgerySettore MED/13 - Endocrinologia03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCombined treatmentCabergolineInternal medicineAcromegalymedicineHumansErgolinesSalvage TherapyCotreatmentlcsh:RC648-665Medical treatmentSomatostatin receptorbusiness.industryHuman Growth HormoneGeneral Medicinemedicine.diseasePrognosisResistantPasireotideHormonesPasireotidechemistry030220 oncology & carcinogenesisPegvisomantAcromegalyDrug Therapy CombinationAcromegaly; Cotreatment; Pasireotide; Pegvisomant; ResistantbusinessSomatostatinmedicine.drugBMC Endocrine Disorders
researchProduct